Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
AMW4 periods SHS VI	Pharma	Germany	SHS Gesellschaft für Beteiligungsmanagement	2014	12yr	Active	–	–
STADA Arzneimittel3 periods CM-CIC Debt Fund 2	Pharma	Germany	CIC Private Debt	2017	9yr	Active	–	–
itm (ITM) Capmont Private Equity	Pharma	Germany	Capmont	2018	8yr	Exited 2026	Telix Pharmaceuticals Limited	–
APONTIS PHARMA Paragon Fund II	Pharma	Germany	Paragon Partners	2018	6yr	Exited 2024	Zentiva	–
Pharmalex Auctus III	Pharma	Germany	Auctus Capital Partners	2014	8yr	Exited 2022	Cencora (AmerisourceBergen)	–
Neuraxpharm3 periods CM-CIC Debt Fund 3	Pharma	Germany	CIC Private Debt	2016	6yr	Active	–	3.5x
PharmaZell4 periods Europe VI (BE VI)	Pharma	Germany	Bridgepoint	2006	6yr	Active	–	–
Riemser Ardian Buyout Fund V	Pharma	Germany	Ardian	2012	8yr	Exited 2020	Esteve	–
KD Pharma2 periods capiton Omega	Pharma	Germany	capiton	2013	7yr	Active	–	–
Lomapharm Lenbach Equity Opportunities I	Pharma	Germany	DUBAG Group	2013	5yr	Exited 2018	Daicel Corporation	–
Zytoservice2 periods IK VIII (Mid Cap)	Pharma	Germany	IK Partners	2008	10yr	Active	–	–
OctreoPharm VC Fonds Technologie Berlin	Pharma	Germany	IBB Ventures	2011	4yr	Exited 2015	Ipsen	–
ACTIVAERO BayBG Venture Capital	Pharma	Germany	BayBG Bayerische Beteiligungsgesellschaft	2005	9yr	Exited 2014	Vectura Group	–
Celesio Haniel Family Equity	Pharma	Germany	Franz Haniel & Cie	1973	41yr	Exited 2014	McKesson	–
Nuvisan ADCURAM Group Holding	Pharma	Germany	ADCURAM Group	2010	4yr	Exited 2014	Family office and management	–
ZellBios AMB I	Pharma	Germany	Apheon	2007	6yr	Exited 2013	Deutsche Private Equity	–
Novosis SHS II	Pharma	Germany	SHS Gesellschaft für Beteiligungsmanagement	2001	5yr	Exited 2006	Acino	–
ROTOP Pharmaka3 periods GENUI III	Pharma	Germany	GENUI	2024	2yr	Active	–	–
1Q Health NORD Holding Mid Cap	Pharma	Germany	NORD Holding	2024	2yr	Active	–	–
4TEEN4 Pharmaceuticals GmbH Fruehphasen- und Wachstumsfonds Brandenburg	Pharma	Germany	Brandenburg Kapital	2019	7yr	Active	–	–
Addvance Group capiton V	Pharma	Germany	capiton	2021	5yr	Active	–	–
Alfavet Aurica Search Fund I	Pharma	Germany	Aurica Capital Desarrollo	2024	2yr	Active	–	–
ALGIAX HTGF II	Pharma	Germany	High-Tech Gruenderfonds (HTGF)	2012	14yr	Active	–	–
Apurano Capmont Private Equity	Pharma	Germany	Capmont	2023	3yr	Active	–	–
AspiAir ATON Evergreen Holding	Pharma	Germany	ATON GmbH	2019	7yr	Active	–	–
Axplora Europe VI (BE VI)	Pharma	Germany	Bridgepoint	2020	6yr	Active	–	–
Biofrontera AG Deutsche Balaton Evergreen Holding (Balance Sheet)	Pharma	Germany	Deutsche Balaton Aktiengesellschaft	2019	7yr	Active	–	–
Cheplapharm CIC Debt Fund 4	Pharma	Germany	CIC Private Debt	2022	4yr	Active	–	–
Demecan Holding GmbH Technologiefonds Hessen	Pharma	Germany	BMH Beteiligungsmanagement Hessen	2021	5yr	Active	–	–
leon-nanodrugs GmbH BayBG Venture Capital	Pharma	Germany	BayBG Bayerische Beteiligungsgesellschaft	2020	6yr	Active	–	–
MiP Pharma capiton VI	Pharma	Germany	capiton	2020	6yr	Active	–	–
MPA Pharma Hannover Finanz Evergreen Fund	Pharma	Germany	Hannover Finanz	1998	28yr	Active	–	–
NEC MED PHARMA GmbH NORD Holding Mid Cap	Pharma	Germany	NORD Holding	2016	10yr	Active	–	–
Novaliq dievini Hopp BioTech holding (Evergreen Balance Sheet)	Pharma	Germany	dievini Hopp BioTech holding	2007	19yr	Active	–	–
PerioTrap Pharmaceuticals GmbH Fraunhofer Venture (spin-off equity)	Pharma	Germany	Fraunhofer Venture	2018	8yr	Active	–	–
ProJect Pharmaceutics AFINUM IX Buyout (2021)	Pharma	Germany	AFINUM Management GmbH	2025	1yr	Active	–	–
almapharm Armira Evergreen	Pharma	Germany	Armira	2024	2yr	Active	–	–
Atec Pharmatechnik GmbH GBK Evergreen Holdings	Pharma	Germany	GBK Beteiligungen AG	2022	4yr	Active	–	–
Clinigen Triton Fund V	Pharma	Germany	Triton Partners	2022	4yr	Active	–	–
cormeo Bertelsmann Digital Media Investments (BDMI)	Pharma	Germany	Bertelsmann Investments	2025	1yr	Active	–	–
Euro Vital Pharma Apera Private Debt Fund II	Pharma	Germany	Apera Asset Management	2021	5yr	Active	–	–
Frontier Biosolutions Flerie Invest	Pharma	Germany	Flerie	2023	3yr	Active	–	–
GPW Holding Silver Investment Partners	Pharma	Germany	Silver Investment Partners	2020	6yr	Active	–	–
Queisser Pharma HGDF Evergreen Holding	Pharma	Germany	HGDF Familienholding	1976	50yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.